Apple's new sensor, digital therapeutics, and digital health diversity

It's a bit of a pot pourri this week as the MobiHealthNews team shares some of what they've heard at a variety of (virtual, of course) industry events. First host Jonah Comstock recaps what Apple announced at its product launch event last week, then Associate Editors Dave Muoio and Mallory Hackett discuss the Digital Therapeutics East event. Finally Managing Editor Laura Lovett and Jonah talk about the Rock Health Summit.And if you haven't gotten enough of events yet, we've got one of our own coming up next week. VIsit https://www.himss.org/event-accelerate-health to learn more about Accelerate Health.Talking points:Apple Watch’s new blood oxygenation sensorNew studies from AppleApple’s “Peloton” killer, Fitness+The role of digital therapeutics in COVID-19 responseDecentralized clinical trials in a pandemic worldThe importance of clinical trial efficacy dataPharma’s perspective on digital therapeuticsThe need for diversity in the digital health startup ecosystemMore about this episode:Apple adds SpO2 & V02 Max to Apple Watch Series 6, and launches three new studiesApple, Anthem launch 2-year study of asthma app, connected devicesApple plants a flag in the home fitness market with Fitness+ for Apple WatchApple Watch sleep tracking feature is more about habits than graphs (VIDEO)Hands-on with Apple Watch's New Blood oxygenation sensor (VIDEO)Why digital therapeutics are flourishing under COVID-19Pharma companies don’t want unicorn digital therapeutic partnershipsDTx regulatory teams talk the power of research beyond ticking FDA's boxesWith many regulatory barriers clear, remaining roadblocks for digital therapeutics are cultural, logisticalTo boost inclusivity, words matter in the healthcare worldWhat startups are missing when they talk about the 'consumer' experience